Advance Search
LIU Hua, MA Haijian, GONG Hongchao. Risk warning management in pregnant women with late threatened abortion by magnesium sulfate treatment[J]. Journal of Clinical Medicine in Practice, 2020, 24(17): 118-121. DOI: 10.7619/jcmp.202017032
Citation: LIU Hua, MA Haijian, GONG Hongchao. Risk warning management in pregnant women with late threatened abortion by magnesium sulfate treatment[J]. Journal of Clinical Medicine in Practice, 2020, 24(17): 118-121. DOI: 10.7619/jcmp.202017032
shu

Risk warning management in pregnant women with late threatened abortion by magnesium sulfate treatment

  • Department of Gynecology, Affiliated Hospital of Yangzhou University, Yangzhou, Jiangsu, 225002

More Information
  • Received Date: May 25, 2020
  • Available Online: September 29, 2020
    Graphical Abstract
    • Abstract
  • Objective To observe effect of risk warning management in pregnant women with late threatened abortion by magnesium sulfate treatment. Methods A total of 22 pregnant women with late threatened abortion by treatment of magnesium sulfate from January to December 2019 were selected as observation group, and they were conducted with whole process risk warning management. Another 25 pregnant women without risk warning management before 2019 were selected as control group. The mastery degree of risk warning management indicators(score for mastery of drug knowledge, score for standard manipulations of magnesium sulfate and infusion pump, score for quality control inspection of high-risk drug management)of nurses in charge of pregnant women in both groups were compared. The satisfaction degree of pregnant women to nursing services, scores of Self-rating Anxiety Scale(SAS)and Self-rating Depression Scale(SDS), and nursing risk events were compared between the two groups. Results Score for mastery of drug knowledge, score for standard manipulations of magnesium sulfate and infusion pump, and score for quality control inspection of high-risk drug management of nurses in charge of pregnant women in the observation group were significantly higher than those in the control group(P<0.05). The satisfaction degree of pregnant women in the observation group was 90.91%(20/22), which was significantly higher than 64.00%(16/25)in the control group(P<0.05). The scores of SAS and SDS in the observation group were significantly lower than those in the control group(P<0.05). The incidence of nursing risk events in the observation group was significantly lower than that in the control group(P<0.05). Conclusion Risk warning management can effectively reduce the incidence of nursing risk events, enhance the risk awareness and prevention ability of nursing staffs, increase the satisfaction degree of pregnant women, and ensure safety of pregnant women.
    • FullText(HTML)
    • References (10)
  • 叶小丽, 吴志军, 许园姣. 不同宫缩抑制剂在先兆早产治疗中临床疗效与安全性的研究[J]. 中国妇幼健康研究, 2017, 28(8): 957-960.
    马燕, 陈丹青. 早产药物治疗的循证评价[J]. 实用妇产科杂志, 2019, 35(7): 489-491.
    刘爱莲. 盐酸利托君与硫酸镁治疗早产临床效果与安全性研究[J]. 世界最新医学信息文摘, 2019, 19(73): 134-135.
    马腾, 周莉. 硫酸镁对早产儿脑神经保护作用的研究进展[J]. 中国医刊, 2020, 55(2): 130-133.
    金晶, 邹丽. 硫酸镁对胎儿及新生儿的影响[J]. 妇产与遗传: 电子版, 2014, 4(1): 45-48.
    HANLEY M, SAYRES L, REIFF E S, et al, Tocolysis: a review of the literature[J]. Obstet Gynecol Surv, 2019, 74(1): 50-55.
    DOYLE LW, CROWTHER CA, MIDDLETON P, et al. Magnesium sulphate for women at risk of preterm birth for neuroprotection of the fetus[J]. Cochrane Database Syst Rev, 2009(1): CD004661.
    刘洋铭, 王寒冰, 漆洪波. 美国妇产科医师学会早产管理指南2016年补充公告解读[J]. 中国实用妇科与产科杂志, 2016, 32(12): 1189-1192.
    韩雪玲, 杜晓琴. 硫酸镁对有早产风险孕妇胎儿神经保护的研究进展[J]. 继续医学教育, 2017, 31(6): 144-146.
    殷祝美. 盐酸利托君与硫酸镁治疗早产临床效果与安全性分析[J]. 临床合理用药杂志, 2017, 10(23): 61-62.
    • Related Articles

  • Related Articles

    [1]YANG Mei, PEI Bo, CHEN Dian. Effect of selenium yeast on short-term efficacy in concurrent chemoradiotherapy for cervical cancer[J]. Journal of Clinical Medicine in Practice, 2021, 25(22): 35-37. DOI: 10.7619/jcmp.20211191
    [2]PEI Bo, CHEN Jiaquan, DUAN Chunyan, YANG Mei, HE Du, CHEN Dian. Efficacy and safety of lobaplatin combined with radiotherapy versus cisplatin plus radiotherapy for locally advanced cervical cancer[J]. Journal of Clinical Medicine in Practice, 2021, 25(6): 106-109. DOI: 10.7619/jcmp.20201865
    [3]LIU Chunmei, LI Ming, ZHAO Gang. A systematic analysis in efficacy and safety of nimotuzumab combined with concurrent chemoradiotherapy in treatment of advanced esophageal cancer[J]. Journal of Clinical Medicine in Practice, 2021, 25(5): 10-15. DOI: 10.7619/jcmp.20201731
    [4]LI Hongzhi, WANG Honggang. Clinical effect of preoperative concurrent chemoradiotherapy with oxaliplatin and capecitabine in treatment of patients with medium to advanced rectal cancer[J]. Journal of Clinical Medicine in Practice, 2019, 23(23): 51-54. DOI: 10.7619/jcmp.201923015
    [5]LIU Fan, WANG Dan, ZHENG Xu. Effect of concurrent chemoradiothrapy on squamous cell carcinoma antigen and carcinoembryonic antigen levelsin patients with intermediate-advanced cervical cancer[J]. Journal of Clinical Medicine in Practice, 2019, 23(18): 36-38. DOI: 10.7619/jcmp.201918011
    [6]GENG Wei, ZHOU Jundong, CAO Haiying. Effect comparison between weekly cisplatin chemotherapy and paclitaxel liposome plus concurrent radiotherapy in the treatment of patients with middle and advanced cervical cancer[J]. Journal of Clinical Medicine in Practice, 2015, (24): 53-55. DOI: 10.7619/jcmp.201524016
    [7]FU Juan, ZHANG Aiyun, DU Junhua, OU Baoquan, YIN Yifa. Effect observation of concurrent radiochemotherapy combined with deep hyperthermia in treatment of patients with locally advanced cervical cancer[J]. Journal of Clinical Medicine in Practice, 2015, (13): 59-61,65. DOI: 10.7619/jcmp.201513018
    [8]ZHANG Jingyi, HU Yongsheng, ZHANG Hongjun, WANG Xi, SHI Guobing. Application of nedaplatin and paclitaxel in the concurrent radiochemotherapy of cervical carcinoma[J]. Journal of Clinical Medicine in Practice, 2014, (7): 88-90. DOI: 10.7619/jcmp.201407029
    [9]JIN HONG, ZHANG Yunyan, LI Qi. Therapeutic effect of concurrent chemoradiotherapy combined with sodium cantharidate vitamin B6 injection for advanced cervical cancer[J]. Journal of Clinical Medicine in Practice, 2013, (19): 149-151. DOI: 10.7619/jcmp.201319057
    [10]TIAN Xiu-mei. Nursing of radiotherapy combined with concurrent chemotherapy by low dose 5- Fu plus Cisplatin in advanced uterine cervical cancer[J]. Journal of Clinical Medicine in Practice, 2012, (2): 13-16. DOI: 10.3969/j.issn.1672-2353.2012.02.006

  • Cited by

    Periodical cited type(21)

    1. 喻洁明，任荣飞，陈晓亮. 耳内镜下应用耳屏软骨-软骨膜复合体行Ⅰ型鼓室成形术的临床疗效研究. 中国医学文摘(耳鼻咽喉科学). 2024(01): 130-132+108 .
    2. 黄献明，覃雪君，谭宇敏. 干湿耳状态下耳内镜下耳屏软骨-软骨膜Ⅰ型鼓室成形术远期疗效比较. 实用医院临床杂志. 2024(05): 157-160 .
    3. 徐美玲，林金成. 内镜下鼓室成形术治疗慢性化脓性中耳炎的效果. 中国当代医药. 2022(06): 89-91 .
    4. 杨礼宏，陈登胜，刘忠意，袁树金. 耳内镜下嵌入蝶形软骨鼓膜成形术治疗鼓膜前缘穿孔效果及对患者听力恢复的影响. 临床和实验医学杂志. 2021(01): 107-110 .
    5. 颜挺. 耳内镜下鼓膜成形术治疗慢性化脓性中耳炎的疗效观察. 临床研究. 2021(08): 17-18 .
    6. 尹新平，李玎，彭敏，刘璐璐，张红. 完桥式鼓室成形术治疗慢性中耳乳突炎临床应用. 中国药物与临床. 2021(16): 2816-2818 .
    7. 唐强，蒋中莉，禹林，梁绍伟，王智勇. 耳内镜下应用耳屏软骨-软骨膜复合体行Ⅰ鼓室成型术的效果研究. 系统医学. 2021(16): 38-40 .
    8. 刘武科. 耳内镜下鼓室成形术后鼓膜穿孔再修补的临床疗效观察. 医学食疗与健康. 2020(01): 69+72 .
    9. 徐继峰，李巍. 耳内镜下耳屏软骨—软骨膜修补鼓膜大穿孔临床疗效. 中国医学文摘(耳鼻咽喉科学). 2020(01): 43-45+4 .
    10. 刘文波，张丽华，李敏，孙青. 耳内镜下与耳科显微镜下鼓膜修补术的临床应用比较. 中国医药指南. 2020(12): 71-72 .
    11. 胡连德. 应用耳屏软骨与软骨膜复合体行耳内镜下修补鼓膜术的效果. 黑龙江医药. 2020(03): 675-677 .
    12. 李和，吴小娟，唐泺，樊利，曹刘. 耳内镜下应用耳屏软骨-软骨膜复合体行鼓室成型术的临床效果. 中国医学文摘(耳鼻咽喉科学). 2020(05): 368-369 .
    13. 张映国，陈胜津，陈丽芬，黄辉强，刘扬，卓芳年. 耳内镜下应用耳屏软骨-软骨膜复合体行Ⅰ型鼓室成形术的临床疗效研究. 中国实用医药. 2020(31): 37-39 .
    14. 林碧玉，李瑞玉，王一红. 耳内镜下与显微镜下鼓膜修补术的临床应用对比. 中国医学创新. 2020(35): 44-47 .
    15. 包勇正，邹文兰，胡志邦，马敬. 29例鼓膜大穿孔患者耳内镜下鼓膜成形术疗效观察. 实用临床医药杂志. 2020(23): 42-44 . 本站查看
    16. 熊斌，张小安，赖文敏，陈庭辉，王跃武. 显微镜联合耳内镜在鼓室成形术中的临床应用. 中国现代医生. 2020(32): 85-88 .
    17. 苏宏钊，廖海石，唐国鹏，林云雁. 耳内镜下采用耳屏软骨-软骨膜修补鼓膜穿孔的疗效观察. 临床医学. 2019(06): 52-54 .
    18. 邸远志，闫辉，周雪芳，吴照红. 耳内镜下Ⅰ型鼓室成形干湿耳手术199例疗效观察. 中国处方药. 2019(10): 145-146 .
    19. 闫强. 耳内镜下耳屏软骨-软骨膜复合体行鼓室成形术对鼓膜愈合及听力恢复影响效果. 中国疗养医学. 2019(10): 1077-1079 .
    20. 王龙海. 耳内镜与显微镜下分别行耳屏软骨环-软骨膜修补术治疗鼓膜穿孔对比观察. 中国疗养医学. 2019(10): 1082-1084 .
    21. 操启友. 耳内镜与显微镜下鼓膜修补术治疗慢性化脓性中耳炎鼓膜穿孔的疗效比较. 中国医学创新. 2019(30): 69-72 .

    Other cited types(0)

Catalog

    Get Citation
    PDF
    XML
    Article views (357) PDF downloads (14) Cited by(21)
    Turn off MathJax
    Article Contents
    Abstract
    References
    Related Articles

    © 2020 《实用临床医药杂志》编辑部

    Address: 江苏省扬州市江阳中路136号，扬州大学江阳路北校区14号楼201室China Pos: 225009Tel: 0514-87978917、87978989、87978807

    苏公网安备 32100302010246号

    Supported by: Beijing Renhe Information Technology Co., Ltd.   Baidu Analytics

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return